glutamine has been researched along with pci 32765 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, Q; Che, Y; Chen, Z; Jiang, VC; Jordan, A; Leeming, A; Li, L; Li, Y; Liu, Y; Nie, L; Vargas, J; Wang, M; Wang, W; Yao, Y | 1 |
1 other study(ies) available for glutamine and pci 32765
| Article | Year |
|---|---|
Targeting glutaminase is therapeutically effective in ibrutinib-resistant mantle cell lymphoma.
Topics: Adult; Cell Line, Tumor; Drug Resistance, Neoplasm; Enzyme Inhibitors; Glutaminase; Glutamine; Humans; Lymphoma, Mantle-Cell; Neoplasm Recurrence, Local | 2023 |